ArticleOncotarget2017

Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity.

Daniel O Villarreal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.